Page last updated: 2024-09-02

anecortave acetate and Day Blindness

anecortave acetate has been researched along with Day Blindness in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barthelmes, D; Fleischhauer, JC; Hayek, S; Helbig, H; Kurz-Levin, MM; Menghini, M; Scherrer, M; Sutter, FK1
Arnold, J; Hunyor, A; Karacorlu, M; Kelly, S; Wilson, D1

Trials

1 trial(s) available for anecortave acetate and Day Blindness

ArticleYear
First clinical experience with anecortave acetate (Retaane).
    Klinische Monatsblatter fur Augenheilkunde, 2007, Volume: 224, Issue:4

    Topics: Aged; Angiogenesis Inhibitors; Choroidal Neovascularization; Female; Humans; Injections; Macular Degeneration; Male; Pilot Projects; Pregnadienediols; Treatment Outcome; Vision Disorders; Visual Acuity

2007

Other Studies

1 other study(ies) available for anecortave acetate and Day Blindness

ArticleYear
Diagnostic and therapeutic challenges.
    Retina (Philadelphia, Pa.), 2007, Volume: 27, Issue:8

    Topics: Adult; Angiogenesis Inhibitors; Combined Modality Therapy; Epiretinal Membrane; Female; Fluorescein Angiography; Hemangioblastoma; Humans; Laser Coagulation; Macular Edema; Neoplasm Recurrence, Local; Pregnadienediols; Retinal Neoplasms; Retinal Neovascularization; Vision Disorders; Visual Acuity; von Hippel-Lindau Disease

2007